Polycystic ovary syndrome: dynamic contrast-enhanced ovary MR imaging
CZ Erdem, U Bayar, LO Erdem, A Barut, S Gundogdu, E Kaya
article (Uluslararası, Hakemli) | Yazar(lar): CZ Erdem, U Bayar, LO Erdem, A Barut, S Gundogdu, E Kaya | Yıl: 2004 | Dergi/Kurum: EUROPEAN JOURNAL OF RADIOLOGY | İndeks: WOS.SCI | DOI: 10.1016/j.ejrad.2003.08.005 | Anahtar Kelimeler: ovary, polycystic ovary syndrome, dynamic contrast-enhanced magnetic resonance imaging
Objective: to determine the enhancement behaviour of the ovaries in women with polycystic ovary syndrome (PCOS) by dynamic contrast-enhanced magnetic resonance (DCE-MR) imaging and to compare these data with those of normal ovulating controls. Method: 24 women with PCOS and 12 controls underwent DCE-MR imaging. Dynamic imagoes were acquired before and after injection of a contrast bolus at 30 s and the min of 1, 2, 3, 4 and 5. On postprocessing examination: (i) the ovarian volumes; (ii) the signal intensity value of each ovary per dynamic study; (iii) early-phase enhancement rate; (iv) time to peak enhancement (T-p); and (v) percentage of washout of 5th min were determined. Data of the ovaries of the women with PCOS and controls were compared with Mann-Whitney U-test. Results: the mean values of Tp were found to be significantly lower in women with PCOS than in controls (p < 0.05). On the other hand, the mean values of ovarian volume, the early-phase enhancement rate, and percentage of washout of 5th min of ovaries were significantly higher in PCOS patients (p < 0.05). Examination of the mean signal intensity-time curve revealed the ovaries in women with PCOS showed a faster and greater enhancement and wash-out. Conclusion: the enhancement behaviour of ovaries of women with PCOS may be significantly different from those of control subjects on DCE-MR imaging examination. In our experience, it is a valuable modality to highlight the vascularization changes in ovarian stroma with PCOS. We believe that improved DCE-MR imaging techniques may also provide us additional parameters in the diagnosis and treatment strategies of PCOS. (C) 2003 Elsevier Ireland Ltd. All rights reserved.